Cboe UK CHF

Cosmo Pharmaceuticals N.V. (COPNZ.XC)

Compare
64.20
-0.60
(-0.93%)
At close: January 10 at 4:19:31 PM GMT

Earnings Estimate

Currency in USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts --155
Avg. Estimate --19.45M265.77M236.2M
Low Estimate --19.45M256.7M216M
High Estimate --19.45M270M250.3M
Year Ago Sales ----96.72M265.77M
Sales Growth (year/est) ----174.77%-11.13%

EPS Trend

Currency in USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
COPNZ.XC --------
S&P 500 8.70%11.55%14.03%13.42%